Neuroblastoma with N‐myc amplification detected by urine: Mass screening in infants after the sixth month of life
- 1 January 1993
- journal article
- critical commentary
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 21 (9) , 625-626
- https://doi.org/10.1002/mpo.2950210902
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Detection of 1p36 deletions in paraffin sections of neuroblastoma tissuesGenes, Chromosomes and Cancer, 1993
- Neuroblastoma Represents Distinct Clinical-Biologic Entities: A Review and Perspective From the Quebec Neuroblastoma Screening ProjectPediatrics, 1992
- Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomasCancer, 1991
- Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1991
- Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.Journal of Clinical Oncology, 1990
- Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screeningThe Journal of Pediatrics, 1988
- Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastomaBritish Journal of Cancer, 1988